Core One Labs Inc C.COOL

Alternate Symbol(s): CLABF

Healthcare Cannabis

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.

CSE:COOL - Post by User

Core One Labs Inc > Listing application for the CSE

<< Previous

Bullboard Posts

Next >>

Comment by lscfaon Jan 17, 2021 11:36am

211 Views

Post# 32315410

RE:RE:Listing application for the CSE

Applicable now.

lscfa wrote:
Total Funds Available

As of the most recent month end prior to the date of this Listing Statement, the Company had working capital deficiency of approximately $3,248,875. Pursuant to the letter of intent with High Tower Capital Inc., High Tower Capital Inc. will pay $3,000,000 for the Assets and will assume $57,593 and USD$4,015,885 (combined, approximately $5,285,070) of liabilities related to the Assets. As a result of the Asset sale, the company will have working capital of approximately $5,036,195.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments